HEADER LIGASE/LIGASE INHIBITOR 18-JUL-20 7JG0 TITLE HUMAN GAR TRANSFORMYLASE IN COMPLEX WITH GAR SUBSTRATE AND AGF102 TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRIFUNCTIONAL PURINE BIOSYNTHETIC PROTEIN ADENOSINE-3; COMPND 3 CHAIN: A; COMPND 4 EC: 6.3.4.13,6.3.3.1,2.1.2.2; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GART, PGFT, PRGS; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VARIANT: ROSETTA PLYSS; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PHIS-PARALLEL KEYWDS GARFTASE, FORMYLTRANSFERASE, TRANSFORMYLASE, ENZYME PROTEIN KEYWDS 2 INHIBITOR, METABOLISM, ALPHA BETA PROTEIN, ROSSMAN FOLD, LIGASE, KEYWDS 3 LIGASE-LIGASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.WONG-ROUSHAR,C.E.DANN III REVDAT 2 18-OCT-23 7JG0 1 REMARK REVDAT 1 31-MAR-21 7JG0 0 JRNL AUTH A.WALLACE-POVIRK,N.TONG,J.WONG-ROUSHAR,C.O'CONNOR,X.ZHOU, JRNL AUTH 2 Z.HOU,X.BAO,G.E.GARCIA,J.LI,S.KIM,C.E.DANN,L.H.MATHERLY, JRNL AUTH 3 A.GANGJEE JRNL TITL DISCOVERY OF 6-SUBSTITUTED THIENO[2,3-D]PYRIMIDINE ANALOGS JRNL TITL 2 AS DUAL INHIBITORS OF GLYCINAMIDE RIBONUCLEOTIDE JRNL TITL 3 FORMYLTRANSFERASE AND 5-AMINOIMIDAZOLE-4-CARBOXAMIDE JRNL TITL 4 RIBONUCLEOTIDE FORMYLTRANSFERASE IN DE NOVO PURINE JRNL TITL 5 NUCLEOTIDE BIOSYNTHESIS IN FOLATE RECEPTOR EXPRESSING HUMAN JRNL TITL 6 TUMORS JRNL REF BIOORG.MED.CHEM. V. 37 16093 2021 JRNL REFN ESSN 1464-3391 JRNL DOI 10.1016/J.BMC.2021.116093 REMARK 2 REMARK 2 RESOLUTION. 1.98 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX V1.13 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.98 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.66 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 3 NUMBER OF REFLECTIONS : 22671 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.184 REMARK 3 R VALUE (WORKING SET) : 0.183 REMARK 3 FREE R VALUE : 0.212 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.790 REMARK 3 FREE R VALUE TEST SET COUNT : 1087 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.6550 - 3.9661 1.00 2897 156 0.1526 0.1699 REMARK 3 2 3.9661 - 3.1484 1.00 2794 129 0.1612 0.1914 REMARK 3 3 3.1484 - 2.7506 1.00 2757 160 0.1970 0.2233 REMARK 3 4 2.7506 - 2.4991 1.00 2700 157 0.2010 0.2245 REMARK 3 5 2.4991 - 2.3200 1.00 2764 108 0.1853 0.2293 REMARK 3 6 2.3200 - 2.1833 1.00 2733 132 0.2151 0.3022 REMARK 3 7 2.1833 - 2.0739 0.97 2613 135 0.2285 0.2475 REMARK 3 8 2.0739 - 1.9840 0.86 2326 110 0.2942 0.3603 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.240 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.560 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.91 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.72 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -31.8263 19.0061 27.7558 REMARK 3 T TENSOR REMARK 3 T11: 0.2015 T22: 0.1636 REMARK 3 T33: 0.2147 T12: 0.0063 REMARK 3 T13: -0.0266 T23: -0.0215 REMARK 3 L TENSOR REMARK 3 L11: 1.8626 L22: 1.2478 REMARK 3 L33: 2.0662 L12: 0.5132 REMARK 3 L13: 0.9262 L23: 0.4006 REMARK 3 S TENSOR REMARK 3 S11: 0.1453 S12: 0.1366 S13: -0.3668 REMARK 3 S21: -0.0138 S22: 0.0102 S23: 0.0284 REMARK 3 S31: 0.2970 S32: -0.0142 S33: -0.1035 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7JG0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-JUL-20. REMARK 100 THE DEPOSITION ID IS D_1000250630. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-APR-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 4.2.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CMOS REMARK 200 DETECTOR MANUFACTURER : RDI CMOS_8M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22671 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.980 REMARK 200 RESOLUTION RANGE LOW (A) : 39.655 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 8.800 REMARK 200 R MERGE (I) : 0.09200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.98 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 86.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 1.00200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5J9F REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.69 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.58 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS (PH 7.5), 0.222 M NACL, 22% REMARK 280 POLYETHYLENE GLYCOL (PEG) 4000, AND 2% PEG 400, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 66.63667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 33.31833 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 33.31833 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 66.63667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2760 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17080 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 66.63667 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 806 REMARK 465 LYS A 1007 REMARK 465 GLU A 1008 REMARK 465 GLU A 1009 REMARK 465 HIS A 1010 REMARK 465 HIS A 1011 REMARK 465 HIS A 1012 REMARK 465 HIS A 1013 REMARK 465 HIS A 1014 REMARK 465 HIS A 1015 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 904 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 938 -152.64 -123.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1325 DISTANCE = 6.24 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GAR A 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue V97 A 1102 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7JG3 RELATED DB: PDB REMARK 900 7JG3 CONTAINS THE SAME PROTEIN COMPLEXED WITH AGF103 REMARK 900 RELATED ID: 7JG4 RELATED DB: PDB REMARK 900 7JG4 CONTAINS THE SAME PROTEIN COMPELXED WITH AGF131 DBREF 7JG0 A 807 1009 UNP P22102 PUR2_HUMAN 808 1010 SEQADV 7JG0 MET A 806 UNP P22102 INITIATING METHIONINE SEQADV 7JG0 HIS A 1010 UNP P22102 EXPRESSION TAG SEQADV 7JG0 HIS A 1011 UNP P22102 EXPRESSION TAG SEQADV 7JG0 HIS A 1012 UNP P22102 EXPRESSION TAG SEQADV 7JG0 HIS A 1013 UNP P22102 EXPRESSION TAG SEQADV 7JG0 HIS A 1014 UNP P22102 EXPRESSION TAG SEQADV 7JG0 HIS A 1015 UNP P22102 EXPRESSION TAG SEQRES 1 A 210 MET ALA ARG VAL ALA VAL LEU ILE SER GLY THR GLY SER SEQRES 2 A 210 ASN LEU GLN ALA LEU ILE ASP SER THR ARG GLU PRO ASN SEQRES 3 A 210 SER SER ALA GLN ILE ASP ILE VAL ILE SER ASN LYS ALA SEQRES 4 A 210 ALA VAL ALA GLY LEU ASP LYS ALA GLU ARG ALA GLY ILE SEQRES 5 A 210 PRO THR ARG VAL ILE ASN HIS LYS LEU TYR LYS ASN ARG SEQRES 6 A 210 VAL GLU PHE ASP SER ALA ILE ASP LEU VAL LEU GLU GLU SEQRES 7 A 210 PHE SER ILE ASP ILE VAL CYS LEU ALA GLY PHE MET ARG SEQRES 8 A 210 ILE LEU SER GLY PRO PHE VAL GLN LYS TRP ASN GLY LYS SEQRES 9 A 210 MET LEU ASN ILE HIS PRO SER LEU LEU PRO SER PHE LYS SEQRES 10 A 210 GLY SER ASN ALA HIS GLU GLN ALA LEU GLU THR GLY VAL SEQRES 11 A 210 THR VAL THR GLY CYS THR VAL HIS PHE VAL ALA GLU ASP SEQRES 12 A 210 VAL ASP ALA GLY GLN ILE ILE LEU GLN GLU ALA VAL PRO SEQRES 13 A 210 VAL LYS ARG GLY ASP THR VAL ALA THR LEU SER GLU ARG SEQRES 14 A 210 VAL LYS LEU ALA GLU HIS LYS ILE PHE PRO ALA ALA LEU SEQRES 15 A 210 GLN LEU VAL ALA SER GLY THR VAL GLN LEU GLY GLU ASN SEQRES 16 A 210 GLY LYS ILE CYS TRP VAL LYS GLU GLU HIS HIS HIS HIS SEQRES 17 A 210 HIS HIS HET GAR A1101 31 HET V97 A1102 32 HETNAM GAR GLYCINAMIDE RIBONUCLEOTIDE HETNAM V97 N-{5-[4-(2-AMINO-4-OXO-3,4-DIHYDROTHIENO[2,3- HETNAM 2 V97 D]PYRIMIDIN-6-YL)BUTYL]THIOPHENE-2-CARBONYL}-L- HETNAM 3 V97 GLUTAMIC ACID FORMUL 2 GAR C7 H13 N2 O8 P 2- FORMUL 3 V97 C20 H22 N4 O6 S2 FORMUL 4 HOH *125(H2 O) HELIX 1 AA1 GLY A 817 ARG A 828 1 12 HELIX 2 AA2 VAL A 846 ALA A 855 1 10 HELIX 3 AA3 ASN A 863 TYR A 867 5 5 HELIX 4 AA4 ASN A 869 PHE A 884 1 16 HELIX 5 AA5 SER A 899 TRP A 906 1 8 HELIX 6 AA6 ASN A 925 GLY A 934 1 10 HELIX 7 AA7 THR A 967 SER A 992 1 26 SHEET 1 AA1 7 THR A 859 VAL A 861 0 SHEET 2 AA1 7 GLN A 835 SER A 841 1 N SER A 841 O ARG A 860 SHEET 3 AA1 7 ARG A 808 ILE A 813 1 N VAL A 809 O GLN A 835 SHEET 4 AA1 7 ILE A 888 LEU A 891 1 O CYS A 890 N ALA A 810 SHEET 5 AA1 7 MET A 910 HIS A 914 1 O LEU A 911 N LEU A 891 SHEET 6 AA1 7 VAL A 937 PHE A 944 -1 O THR A 941 N HIS A 914 SHEET 7 AA1 7 ILE A 954 PRO A 961 -1 O VAL A 960 N THR A 938 SHEET 1 AA2 2 VAL A 995 LEU A 997 0 SHEET 2 AA2 2 ILE A1003 TRP A1005 -1 O CYS A1004 N GLN A 996 CISPEP 1 LEU A 918 PRO A 919 0 12.25 SITE 1 AC1 19 THR A 816 GLY A 817 SER A 818 ASN A 819 SITE 2 AC1 19 GLY A 893 MET A 895 HIS A 914 PRO A 915 SITE 3 AC1 19 GLY A 923 LYS A 976 GLU A 979 V97 A1102 SITE 4 AC1 19 HOH A1206 HOH A1225 HOH A1229 HOH A1237 SITE 5 AC1 19 HOH A1245 HOH A1252 HOH A1255 SITE 1 AC2 16 HIS A 864 ARG A 870 PHE A 894 MET A 895 SITE 2 AC2 16 ARG A 896 ILE A 897 LEU A 898 VAL A 903 SITE 3 AC2 16 ASN A 912 VAL A 945 ALA A 946 GLU A 947 SITE 4 AC2 16 VAL A 949 ASP A 950 GAR A1101 HOH A1207 CRYST1 75.232 75.232 99.955 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013292 0.007674 0.000000 0.00000 SCALE2 0.000000 0.015349 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010005 0.00000